Ah Bio Fund Iv, L.p.
10% owner
Conversion
Calculated transaction value
$0
40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Braveheart Bio, Inc.
BRVE
Transactions reported in official disclosures
34 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Ah Bio Fund Iv, L.p. 10% owner | Aug 11, 2026 4-day lag | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ah Bio Fund Iv, L.p. 10% owner | Aug 11, 2026 4-day lag | Conversion Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Ah Bio Fund Iv, L.p. 10% owner | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $19.8M Filed shares x price | SEC Form 4 View filing | |
| Chimovits Erez Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Chimovits Erez Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $4.92M Filed shares x price | SEC Form 4 View filing | |
| Chimovits Erez Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $30M Filed shares x price | SEC Form 4 View filing | |
| Chimovits Erez Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Conversion Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $4.92M Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Conversion Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Buy Aug 7, 2026 | $30M Filed shares x price | SEC Form 4 View filing | |
| Orbimed Advisors Llc Director / Ten Percent Owner | Aug 11, 2026 4-day lag | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Jiangsu Hengrui Pharmaceuti... 10% owner | Aug 10, 2026 3-day lag | Conversion Aug 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Jiangsu Hengrui Pharmaceuti... 10% owner | Aug 10, 2026 3-day lag | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Forbion Growth Opportunitie... 10% owner | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $30.24M Filed shares x price | SEC Form 4 View filing | |
| Forbion Growth Opportunitie... 10% owner | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $34.56M Filed shares x price | SEC Form 4 View filing | |
| Forbion Growth Opportunitie... 10% owner | Aug 7, 2026 Same-day filing | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Forbion Growth Opportunitie... 10% owner | Aug 7, 2026 Same-day filing | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Forbion Growth Opportunitie... 10% owner | Aug 7, 2026 Same-day filing | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Forbion Growth Opportunitie... 10% owner | Aug 7, 2026 Same-day filing | Conversion Aug 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Rickey James Paul Chief Financial Officer | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $499.99K Filed shares x price | SEC Form 4 View filing | |
| Rickey James Paul Chief Financial Officer | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lohoff Tim Director | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Chimovits Erez Director / Ten Percent Owner | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Viehbacher Christopher Director | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $1.5M Filed shares x price | SEC Form 4 View filing | |
| Viehbacher Christopher Director | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Malek David I Director | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $74.99K Filed shares x price | SEC Form 4 View filing | |
| Malek David I Director | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Anderson Michele A. Chief Development Officer | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $20K Filed shares x price | SEC Form 4 View filing | |
| Anderson Michele A. Chief Development Officer | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Murdoch Travis CEO And President | Aug 7, 2026 Same-day filing | Buy Aug 7, 2026 | $1.5M Filed shares x price | SEC Form 4 View filing |
Ah Bio Fund Iv, L.p.
10% owner
Conversion
Reported value range
Not reported
9,132,420 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Ah Bio Fund Iv, L.p.
10% owner
Buy
Calculated transaction value
$19.8M
1,100,000 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Chimovits Erez
Director / Ten Percent Owner
Conversion
Calculated transaction value
$0
40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Chimovits Erez
Director / Ten Percent Owner
Buy
Calculated transaction value
$4.92M
273,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Chimovits Erez
Director / Ten Percent Owner
Buy
Calculated transaction value
$30M
1,666,667 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Chimovits Erez
Director / Ten Percent Owner
Conversion
Reported value range
Not reported
9,132,420 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Orbimed Advisors Llc
Director / Ten Percent Owner
Buy
Calculated transaction value
$4.92M
273,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Orbimed Advisors Llc
Director / Ten Percent Owner
Conversion
Reported value range
Not reported
9,132,420 shares
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Orbimed Advisors Llc
Director / Ten Percent Owner
Buy
Calculated transaction value
$30M
1,666,667 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Orbimed Advisors Llc
Director / Ten Percent Owner
Conversion
Calculated transaction value
$0
40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 11, 2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10% owner
Conversion
Reported value range
Not reported
7,420,091 shares
Traded
Aug 7, 2026
Filed
Aug 10, 2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10% owner
Conversion
Calculated transaction value
$0
32,500,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 10, 2026
Forbion Growth Opportunities Fund Iii Cooperatief U.a.
10% owner
Buy
Calculated transaction value
$30.24M
1,680,000 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Forbion Growth Opportunities Fund Iii Cooperatief U.a.
10% owner
Buy
Calculated transaction value
$34.56M
1,920,000 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Forbion Growth Opportunities Fund Iii Cooperatief U.a.
10% owner
Conversion
Calculated transaction value
$0
9,132,420 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Forbion Growth Opportunities Fund Iii Cooperatief U.a.
10% owner
Conversion
Calculated transaction value
$0
35,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Forbion Growth Opportunities Fund Iii Cooperatief U.a.
10% owner
Conversion
Calculated transaction value
$0
40,000,000 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Forbion Growth Opportunities Fund Iii Cooperatief U.a.
10% owner
Conversion
Calculated transaction value
$0
7,990,867 shares @ $0
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Rickey James Paul
Chief Financial Officer
Buy
Calculated transaction value
$499.99K
27,777 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Rickey James Paul
Chief Financial Officer
Award
Calculated transaction value
$0
300,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Lohoff Tim
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Chimovits Erez
Director / Ten Percent Owner
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Viehbacher Christopher
Director
Buy
Calculated transaction value
$1.5M
83,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Viehbacher Christopher
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Malek David I
Director
Buy
Calculated transaction value
$74.99K
4,166 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Malek David I
Director
Award
Calculated transaction value
$0
30,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Anderson Michele A.
Chief Development Officer
Buy
Calculated transaction value
$20K
1,111 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026
Anderson Michele A.
Chief Development Officer
Award
Calculated transaction value
$0
300,000 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Murdoch Travis
CEO And President
Buy
Calculated transaction value
$1.5M
83,333 shares @ $18
Traded
Aug 7, 2026
Filed
Aug 7, 2026